A study from South Korea showed that female patients who underwent cancer treatments in the afternoon had better outcomes than those who were treated in the morning. Their five-year mortality rate was reduced by 12.5 times.
Results of the “Temporal Anticancer Therapy” study were released by Kim Jae-kyung, Research Director of the Center for Mathematical and Computational Sciences at the Institute for Basic Science (IBS), and Professor of Mathematical Sciences at KAIST, and Professor Youngil Koh of the Department of Hematology and Oncology at Seoul National University Hospital (SNUH), on Dec. 15.





